Patterns of regional cerebral hypoperfusion in early Parkinson's disease: Clinical implications

Parkinsonism Relat Disord. 2024 Apr:121:106024. doi: 10.1016/j.parkreldis.2024.106024. Epub 2024 Feb 2.

Abstract

Introduction: This study aimed to investigate whether regional cerebral perfusion patterns on early-phase 18F-FP-CIT PET scans, which is typically coupled to cerebral metabolism, predict the long-term prognosis of Parkinson's disease (PD).

Methods: We enrolled 397 drug-naïve patients with early-stage PD who underwent dual-phase 18F-FP-CIT PET scans. After quantifying the early-phase 18F-FP-CIT PET images, cluster analysis was performed to delineate the PD subtypes according to the patterns of regional cerebral perfusion. We compared the risk of developing levodopa-induced dyskinesia (LID), wearing-off, freezing of gait (FOG), and dementia between the PD subtypes.

Results: Cluster analysis classified patients into three subtypes: cluster 1 (relatively preserved cortical uptake; n = 175), cluster 2 (decreased uptake in the frontal, parietal, and temporal regions; n = 151), and cluster 3 (decreased uptake in more extensive regions, additionally involving the lateral occipital regions; n = 71). Cluster 1 was characterized by a younger age-of-onset, less severe motor deficits, less severely decreased 18F-FP-CIT binding in the caudate, and better cognitive performance. Cluster 3 was characterized by an older age-of-onset, more severe motor deficits, and poorer cognitive performance. Cluster 2 was intermediate between clusters 1 and 3. Cox regression analyses demonstrated that clusters 2 and 3 had a higher risk for dementia conversion than cluster 1, whereas the risk for developing LID, wearing-off, and FOG did not differ among the clusters.

Conclusion: The patterns of regional cerebral perfusion can provide information on long-term prognosis with regards to cognitive, but not motor aspects of patients with early-stage PD.

Keywords: (18)F-FP-CIT PET; Cerebral perfusion; Cluster analysis; Dementia; Parkinson's disease.

MeSH terms

  • Dementia*
  • Dopamine Plasma Membrane Transport Proteins / metabolism
  • Gait Disorders, Neurologic*
  • Humans
  • Parkinson Disease* / diagnostic imaging
  • Parkinson Disease* / metabolism
  • Positron-Emission Tomography / methods
  • Tomography, Emission-Computed, Single-Photon / methods
  • Tropanes

Substances

  • 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane
  • Tropanes
  • Dopamine Plasma Membrane Transport Proteins